English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Objective  Lung cancer remains number one cause of cancer related deaths worldwide. Cell cycle deregulation plays a major role in the pathogenesis of Non-Small Cell Lung Cancer (NSCLC). CDC25A represents a critical cell cycle regulator that enhances cell cycle progression. In this study we aimed to investigate the role of a novel CDC25A transcriptional variant, CDC25A Q110del , on the regulation of the CDC25A protein, and its impact on prognosis of NSCLC patients.    Methodology/Principal Findings  Here we report a novel CDC25A transcript variant with codon 110 (Glutamine) deletion, that we termed CDC25A Q110del  in NSCLC cells. In 9 (75%) of the 12 NSCLC cell lines, CDC25A Q110del  expression accounted for more than 20% of the CDC25A transcripts. Biological effects of CDC25A Q110del  were investigated in H1299 and HEK-293F cells using UV radiation, flowcytometry, cyclohexamide treatment, and confocal microscopy. Compared to CDC25A wt , CDC25A Q110del  protein had longer half-life; cells expressing CDC25A Q110del  were more resistant to UV irradiation and showed more mitotic activity. Taqman-PCR was used to quantify CDC25A Q110del  expression levels in 88 primary NSCLC tumor/normal tissue pairs. In patients with NSCLC, Kaplan Meier curves showed tumors expressing higher levels of CDC25A Q110del  relative to the adjacent lung tissues to have significantly inferior overall survival ( P  = .0018).    Significance  Here we identified CDC25A Q110del  as a novel transcriptional variant of CDC25A in NSCLC. The sequence-specific nature of the abnormality could be a prognostic indicator in NSCLC patients as well as a candidate target for future therapeutic strategies.

CDC25AQ110del: A Novel Cell Division Cycle 25A Isoform Aberrantly Expressed in Non-Small Cell Lung Cancer